✦ LIBER ✦

Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?

✍ Scribed by R. Morales-Barrera, C. Suárez, C. Valverde, I. Nuñez…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Do Patients With Platinum-Resistant Epit

✍ Kenji Hashimoto; Noriyuki Katsumata; Taizo Hirata; Kan Yonemori; Tsutomu Kouno; 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 555 KB

Gemcitabine and paclitaxel chemotherapy

✍ Kazumasa Matsumoto; Akira Irie; Takefumi Satoh; Miyoko Okazaki; Masatsugu Iwamur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Do Patients With Advanced Urothelial Car

✍ Florence Joly; Nadine Houédé; Sabine Noal; Christine Chevreau; Frank Priou; Paul 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 157 KB

A phase II trial of docetaxel (Taxotere®

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

DOCETAXEL AND IFOSFAMIDE AS SECOND LINE

✍ KREGE, S.; REMBRINK, V.; BÖRGERMANN, C.H.; OTTO, T.; RÜBBEN, H. 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB

A phase II study of docetaxel and cispla

✍ Daniel T.T. Chua; Jonathan S.T. Sham; Gordon K.H. Au 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB